Apollo Hospitals Enterprise has received approval for investment of an amount not exceeding a sum of Rs 8.5 crore for acquiring 85,00,000 equity shares (50% stake) of Rs 10 each of Apollo Gleneagles PET-CT (AGPCL) from its existing shareholder, Parkway Healthcare (Mauritius), representing capital of AGPCL. Upon completion of the proposed transaction, AGPCL will become a wholly owned subsidiary of the company.

AGPCL is engaged in the business of providing high-end medical diagnostic services through its state-of-the art PET-CT Radio Imaging Centre in Hyderabad. The objective of this acquisition is to consolidate ownership and have full control over AGPCL's operations, enabling better integration with the company's diagnostic services and improving operational efficiencies.

The Board of Directors of the company in its meeting held on August 12, 2025, has approved the same.

Apollo Hospitals Enterprise owns and operates chain of multi-specialty hospitals. It offers the services in the area of cardiology, cardiothoracic, orthopedics and joint replacement, spine surgery, oncology, etc.